Purchases and Sales Made in Q1 2025 in Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA) during Q1 2025. The information is specifically focused on institutions that hold shares of Innate Pharma SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
15.3KNew |
$25.6K - $38.8K
|
15.3K
$27.1K
|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
12.4K+ 104.73% |
$20.7K - $31.4K
|
24.3K
$43K
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
BUY
|
- |
5.49K+ 156.44% |
$9.17K - $13.9K
|
9K
$15.9K
|
|
Apr 07, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
3.98KNew |
$6.64K - $10.1K
|
3.98K
$7.04K
|
|
May 15, 2025
Q1 2025
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3New |
$5.01 - $7.59
|
3
$5.31
|
|
May 14, 2025
Q1 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Apr 14, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-1.74K- 43.82% |
$2.91K - $4.41K
|
2.23K
$3.95K
|
|
Apr 17, 2025
Q1 2025
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-14.6K- 18.87% |
$24.4K - $36.9K
|
62.8K
$111K
|